This study evaluated adherence to treatment, quality of life and subjective well-being in patients with psychosis treated with long-acting injectable risperidone. Subjects enrolled were part of a larger study where patients were observed in an adherence to treatment program of the University of Rome Tor Vergata.
Niolu, C., Bianciardi, E., DI LORENZO, G., Marchetta, C., Barone, Y., Sterbini, N., et al. (2015). Enhancing adherence, subjective well-being and quality of life in patients with schizophrenia: which role for long-acting risperidone?. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 5(5), 278-288 [10.1177/2045125315596897].
Enhancing adherence, subjective well-being and quality of life in patients with schizophrenia: which role for long-acting risperidone?
NIOLU, CINZIA;BIANCIARDI, EMANUELA;DI LORENZO, GIORGIO;MARCHETTA, CLAUDIA;RIBOLSI, MICHELE;SIRACUSANO, ALBERTO
2015-10-01
Abstract
This study evaluated adherence to treatment, quality of life and subjective well-being in patients with psychosis treated with long-acting injectable risperidone. Subjects enrolled were part of a larger study where patients were observed in an adherence to treatment program of the University of Rome Tor Vergata.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
